WC Walker & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
WC Walker & Associates's LLY Position: Q4 2022 in Review
WC Walker & Associates increased its Eli Lilly (LLY) stake by 11% in Q4 2022, buying an estimated $33K and bringing the position to 976 shares worth $321K. The position accounts for 0.17% of the portfolio, ranked #64.
WC Walker & Associates first reported a position in LLY in Q2 2021 and has held it in 7 quarters since. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.
- WC Walker & Associates held 976 shares of Eli Lilly worth $321K as of Q4 2022.
- WC Walker & Associates bought 93 Eli Lilly shares in Q4 2022, an estimated $33K.
- Eli Lilly made up 0.17% of WC Walker & Associates's portfolio in Q4 2022, its #64 holding.
- WC Walker & Associates first reported a position in Eli Lilly in Q2 2021 and has held it in 7 quarters since.
- 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.
Based on WC Walker & Associates's 13F filing for Q4 2022, filed 23 Feb 2023.